• The Tat translocase has captured the interest of the biotechnology industry 14
. Conventional strategies for the isolation of these heterologous, recombinant 48 proteins from E. coli include, expression of soluble proteins in the cytoplasm, expression as 49 insoluble inclusion bodies or export to the periplasm with subsequent outer membrane 50 rupture to release the periplasmic contents (Pooley et al., 1996) . Adoption of the latter 51 approach offers two main advantages: firstly, the oxidizing environment of the periplasm 52 allows disulphide bonds to form, and secondly, rupturing of only the outer membrane of 53
Gram-negative bacteria means there are fewer contaminating cytoplasmic proteins. 54
55
The ability of the twin-arginine translocase (hereafter denoted Tat system) to transport fully-56 folded proteins into the periplasm of Gram-negative bacteria has captured the interest of the 57 biotechnology industry owing to its potential to simplify the downstream processing of high-58 value, biotherapeutic proteins. Initial studies investigated the ability of the Tat translocase to 59 transport a model heterologous protein on a large scale. These studies showed that Tat 60 could export GFP at levels comparable to conventional methods, and with no large-scale 61 release of cytoplasmic contents (Matos et al., 2012) , confirming this machinery's potential 62 as a viable method for producing heterologous protein. system does have considerable potential for the production of single-span heterologous 68 membrane proteins, particularly those that contain a globular domain located on the 69 periplasmic face of the inner membrane. Two studies have shown that it is possible to 'stall' 70 a Tat substrate at the inner membrane by virtue of a substitution mutation in the signal 71 peptidase cleavage site of a TorA signal peptide (Karlsson et al., 2012; Ren et al., 2013) . 72
Both studies used biochemical approaches to demonstrate that a Tat substrate remained 73 membrane-anchored with its mature domain exposed at the periplasmic side of the inner 74 membrane. These data reveal a potential for the Tat translocase to be used in the production 75 of membrane-bound proteins or for bacterial cell-surface display technologies. 76 77 Bacterial surface display involves the presentation of a recombinant protein or peptide on 78 the surface of microorganisms, most common of which is E. coli, owing to its ease of genetic 79 manipulation and ability to produce recombinant proteins in high yields. As the name 80 suggests, this presentation technology results in the protein of interest being positioned on 81 the surface of the cell where it is available for interaction with any externally added substrate, 82 which does not have to penetrate the membrane. Implementation of this technique has 83 proven beneficial for numerous applications, including biofuel production and protein library 84 screening (Wu et al., 2008) . 85
86
A prerequisite of cell surface display in E. coli is that the protein of interest is successfully 87 transported across the inner membrane and into the outer membrane; however, 88 incorporation of foreign proteins in the outer membrane can be toxic to the cell; the presence 89 of lipopolysaccharides can sterically hinder interactions between expressed protein and 90 binding-partner, and assembly at cellular appendages (e.g. flagella or pilli) can disrupt 91 assembly of the recombinant protein (Chen & Georgiou, 2002). Therefore, alternative 92 methods are required that avoid the pitfalls of displaying a protein at the outer membrane. 93
Anchored periplasmic expression is one such alternative that involves display of 94 heterologous protein in the periplasm of E. coli, which is tethered to the inner membrane by 95 a lipoprotein targeting motif (Mazor et al., 2008) . 96
97
The vast majority of proteins that are presented using this method are exported out of the 98 cytoplasm in an unfolded state via the Sec translocon (Driessen & Nouwen, 2008). However, 99 this export is reliant on the recombinant protein refolding to a native, biologically active 100 conformation in the periplasm. Use of Tat machinery to traverse the inner membrane avoids 101 this issue since proteins can be transported fully-folded. This, in combination with data 102
showing that a signal peptide mutation in a Tat substrate is able to stall a Tat precursor at 103 the inner membrane (Ren et al., 2013) , highlights the potential for Tat machinery in cell 104 surface display technology. 105
106
To investigate this further we used biochemical and electron microscopy approaches to 107 analyse the export of a biopharmaceutical, human growth hormone (hGH), which has been 108 shown to be successfully transported by the Tat machinery (Alanen et al., 2015) . hGH is a 109 In this study we have sought to achieve stable expression of a non-cleavable Tat precursor 123 at the inner membrane of E. coli without the addition of amino acid residues to the protein, 124
and we have used immunogold electron microscopy to precisely localise the target proteins 125 for the first time. 
Preparation of E. coli cells for visualisation by electron microscopy 161
Chemical fixation of E. coli cells: E. coli cells (overexpressing either WT or mutant precursor 162 hGH) were resuspended in aldehyde fixative (0.25% glutaraldehyde/4% formaldehyde) and 163 low melting temperature agarose at 1:1 volume ratio. Agarose-enrobed cells were then 164 harvested and incubated on ice until the agarose had set. Cells were diced into 1 mm 3 pieces 165 using a clean razor blade and resuspended in fresh aldehyde fixative for overnight fixation 166 
Immunolabelling of E. coli cells to detect hGH in the inner membrane 182
Using the touching-drop method (Rubinstein, 2007) , ultrathin sections were blocked via 183 incubation in TBS/Tween buffer (0.24% Tris (w/v), 2.5% NaCl (w/v) and 2% Tween-20 (v/v)) 184 pH 8.4 containing 1% BSA (w/v) and 4% normal goat sera (v/v) (Abcam Plc, Cambridge UK) 185
for 30 mins at room temperature (RT). hGH protein was labelled by incubation with primary 186 anti-hGH antibody (rabbit polyclonal) at 1:20000 dilution (TBS/Tween +1% BSA buffer) for 187 2hrs at RT. Sections were then washed with TBS/Tween +1% BSA at RT, and then 188 incubated with 10nm gold-conjugated secondary antibody (Goat anti-rabbit IgG pre-189 adsorbed, Abcam Plc) for 1 hr at RT. Finally, sections were washed in TBS/Tween (+1% 190 BSA) and dH2O and allowed to air dry before insertion into the EM. 228 Export assays demonstrated that Tat-mediated transport of TorA-hGH occurs soon after 229 induction since, after 1 hour, mature hGH is present in the periplasm. There is a minimal 230 amount of precursor protein present in the cytoplasmic fraction, which has also been 231 observed in previous analyses of Tat-dependent export of TorA-hGH (Ren et al., 2013) . 232
Therefore, the lack of cytoplasmic precursor protein in this study could be due to the quick 233 turnover of the substrate from the cytoplasm to the periplasm, or due to proteolytic cleavage 234 of the precursor protein ( Figure 2 ). Quick turnover of the precursor hGH would also explain 235 the lack and/or minimal amount of precursor hGH present at the membrane up until 1hr 30. 236
Only at later time points (1hr 45 and 2hr) do we see a substantial increase in precursor at 237 the membrane, which is consistent with increased production of hGH precursor/Tat 238 substrate. 239
240
To confirm that the export of TorA-hGH is via Tat, an identical export assay was performed 241 in E. coli cells lacking Tat machinery (ΔtatABCDE; hereafter denoted Δtat). The lack of 242 mature hGH in the periplasm of these control cells, at any time point, confirms Tat-243 dependent export of hGH into the periplasm in wild type E. coli (Figure 3) . examined for the presence of gold particles. Use of antibodies specific to hGH avoids the 286 use of (potentially large) affinity tags, and thus permits direct protein detection. Gold particles 287
were classified according to their location, and for the present study, a gold particle found 288 within 25 nm of the inner membrane was defined as being located at the inner membrane. immunogold-labelled with anti-hGH. These cells exhibit a pattern of gold labelling that is 297 predominantly around the periphery of the cell. This was confirmed at increased 298 magnification, as in Figures 5 (bottom row) , where the gold particles could be seen to reside 299 within 25 nm of the inner membrane of the cell wall. Given that the bulk of the protein has 300 been shown to be present in periplasmic fractions using export assays (Figure 2) , we 301 conclude that these particles are indeed located in the periplasm of the cells. A smaller 302 number of particles were present in the cytoplasm. Magnified images of these cells, with 303 close-ups of individual gold particles can be also seen in Supplementary Figure 1 . 304 305 Analysis of E. coli cells that did not express TorA-hGH (representative images shown in 306 Supplementary Figure 2) , showed the presence of only a few gold particles in the 307 cytoplasmic and membranous regions. These data indicate that the antibody is able to 308 detect hGH with a high degree of specificity. As further controls, TorA-hGH-expressing cells 309 were immunolabelled with the primary antibody omitted (Supplementary Figure 3, A and B) , 310
and TEM analysis showed that these cells lacked any gold binding confirming that non-311 specific binding seen in E. coli cells not overexpressing any recombinant protein was 312 attributable to the primary antibody. Finally, the same cell type was immunolabelled with a 313 gold-conjugated secondary antibody directed towards a different animal species 314 ( Supplementary Figure 3, C and D) . TEM analysis showed only unlabeled E. coli cells, 315
confirming that the cells do not have a non-specific attraction for gold particles. bound TorA-hGH is thus highly specific, with the inner membrane/ periplasm of TorA-hGH-326 overexpressing cells containing 9.42-fold more gold particles than the same membrane in 327 E. coli cells that lack overexpression of TorA-hGH. To confirm a statistical independence in 328 immunogold labelling between these cells at the cytoplasm and inner membrane, χ 2 analysis 329 of the raw gold count data was conducted. For a total χ 2 value of 111.2 and 1 degree of 330 freedom P was <0.005. This confirms that the gold labelling distributions between the two 331 cell types are significantly different. respectively. Since the number of gold particles in E. coli cells that lack overexpression of 336 hGH represents non-specific binding, and assuming that the level of non-specific binding in 337 the two cell types is the same, this indicates that TorA-hGH-overexpressing cells contain an 338 average of 1 gold particle per cell in the cytoplasm, which is considerably lower than the 3.8 339 gold particles per cell in the inner membrane/ periplasm region. This difference is consistent 340 with the amount of hGH in the cytoplasmic fraction compared to the membranous 341 compartment of E. coli determined by export assays, which revealed that at 1hr 45 mins 342 after induction, there is considerably more hGH present in the membrane fraction compared 343 to the cytoplasm (Figure 2 ). Our immunolabelling approach thus provides highly specific 344 detection of hGH in both the cytoplasmic and membrane fractions of E. coli. 345
346
Immunogold labelling of TorA-hGH showed this protein is randomly distributed within the E. 347 coli periplasm and cytoplasm, with no evidence for a preferential localisation at the poles or 348 elsewhere ( Figure 5, yellow and red circles, respectively) . This is the first time that a 349 heterologous Tat substrate has been directly visualised after export to the periplasm, and 350 these observations are consistent with the efficient production of hGH in our E. coli cells. The twin-arginine translocase offers potential for the biotechnology industry owing to its 368 ability to transport fully-folded proteins into the periplasm of E. coli. Initial studies confirmed 369 the capability of the Tat system to transport a model heterologous protein to a high yield 370 Anchoring of heterologous Tat substrates in the inner membrane has previously occurred 378 via the addition of extra amino acid residues to the protein sequence (Karlsson et al., 2012) . 379
However, this study has shown that only a single substitution mutation in the signal 380 peptidase cleavage site of a TorA signal peptide, fused to hGH, resulted in the precursor 381 protein being "stalled" at the inner membrane, with no alterations to the mature protein. The 382 previous studies by (Karlsson et al., 2012) and (Ren et al., 2013) showed that cleavage by 383 leader peptidase occurs only after transfer of the mature protein to the periplasm, and given 384 that hGH is exported by Tat in an extremely efficient manner, it is to be expected that the 385 mature hGH protein will be similarly positioned on the periplasmic face of the inner 386 Controls were E. coli cells that lacked expression of hGH protein (labelled -hGH). Raw gold counts were taken from 200 randomly imaged E. coli from 2 separate resin blocks. Gold was assigned to either 'membrane + periplasm' (labelled membrane) or cytoplasm compartment. The approximate numbers of gold particles at the cytoplasm and membrane fraction of each cell were calculated for each cell type. There was 2.2X more gold in the cytoplasm (line-patterned) of hGH expressing cells versus those lacking hGH expression. There was 9.43x more gold in the membrane (dotted pattern) of hGH expressing cells versus those lacking hGH expression. Error bars: CI of 2x SE. The labelling of hGH between the two cell types is statistically significant (indicated by ++). Ultrathin sections of E. coli cells overexpressing TorA-hGH (mutant precursor) were immunolabelled using a polyclonal antibody raised against hGH (shown in rows 1-3, with row 4 showing close-ups of individual gold particles from row 3). At 1hr 45 min after induction, hGH was found to exhibit a random distribution in the inner membrane (yellow circles) and was also present in the cytoplasm (red circles). Images were taken on a JEOL 2010F at 15,000X magnification. Scale bar = 200 nm.
